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The ERK/MAPK intracellular signaling pathway is hypothesized to be a key regulator of striatal activity via modulation of synaptic
plasticity and gene transcription. However, prior investigations into striatal ERK/MAPK functions have yielded conflicting results.
Further, these studieshavenotdelineated the cell-type-specific roles of ERK/MAPKsignalingdue to the relianceonglobally administered
pharmacological ERK/MAPK inhibitors and the use of genetic models that only partially reduce total ERK/MAPK activity. Here, we
generated mouse models in which ERK/MAPK signaling was completely abolished in each of the two distinct classes of medium spiny
neurons (MSNs). ERK/MAPK deletion in D1R-MSNs (direct pathway) resulted in decreased locomotor behavior, reduced weight gain,
and early postnatal lethality. In contrast, loss of ERK/MAPK signaling in D2R-MSNs (indirect pathway) resulted in a profound hyperlo-
comotor phenotype. ERK/MAPK-deficient D2R-MSNs exhibited a significant reduction in dendritic spine density, markedly suppressed
electrical excitability, and suppression of activity-associated gene expression even after pharmacological stimulation. Our results dem-
onstrate the importance of ERK/MAPK signaling in governing the motor functions of the striatal direct and indirect pathways. Our data
further show a critical role for ERK in maintaining the excitability and plasticity of D2R-MSNs.
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Introduction
The basal ganglia govern a vast array of psychomotor behaviors
(Nelson and Kreitzer, 2014; Graybiel and Grafton, 2015). Senso-
rimotor information is integrated into the basal ganglia via the
striatum, where glutamatergic and dopaminergic inputs con-
verge onto two distinct classes ofmedium spiny neurons (MSNs)
(Gerfen et al., 1990; Kawaguchi et al., 1990; Gong et al., 2007;
Cerovic et al., 2013). Direct-pathway MSNs (D1R-MSNs) ex-
press the dopamine 1 receptor (D1) and largely project to the
substantia nigra reticulata (SNr) and globus pallidus internae
(GPi). Indirect-pathway MSNs (D2R-MSNs) express dopamine
2 (D2) and adenosine A2a (A2a) receptors and predominantly
target the globus pallidus externae (GPe). Experimental evidence
suggests that D1R-MSN and D2R-MSN activities have opposing
actions. In the motor system, stimulation of the direct pathway
elicits activation of motor behaviors, whereas stimulation of the
indirect pathway inhibits motor activity (Kravitz et al., 2010; Far-
rell et al., 2013). Silencing each pathway has the converse effects
(Durieux et al., 2009; Hikida et al., 2010).
The convergence of glutamatergic and dopaminergic signaling
onto MSNs leads to long-term alterations in neuronal excitability,
changes in activity-induced gene expression and modulation of
dendritic spine density (Cerovic et al., 2013; Nelson and Kreitzer,
2014). A major signaling pathway implicated in mediating these
long-lasting changes is ERK/MAPK (ERK) (Thomas and Huganir,
2004; Pascoli et al., 2014). Glutamatergic stimulation leads to
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Significance Statement
Alterations in ERK/MAPKactivity are associatedwith drug abuse, aswell as neuropsychiatric andmovement disorders. However,
genetic evidence defining the functions of ERK/MAPK signaling in striatum-related neurophysiology and behavior is lacking.We
show that loss of ERK/MAPK signaling leads to pathway-specific alterations inmotor function, reduced neuronal excitability, and
the inability of medium spiny neurons to regulate activity-induced gene expression. Our results underscore the potential impor-
tance of the ERK/MAPK pathway in humanmovement disorders.
8102 • The Journal of Neuroscience, August 23, 2017 • 37(34):8102–8115
ERK activation through a NMDAR-mediated calcium-
dependentmechanism (Krapivinsky et al., 2003;Mao et al., 2004;
Valjent et al., 2005), whereas dopamine differentially regulates
ERK activity based on the dopamine receptor subtypes expressed
by the neuron (Calabresi et al., 2014). Therefore, ERK is hypoth-
esized to initiate appropriate cellular responses to patterned ac-
tivity from different classes of presynaptic input (Valjent et al.,
2005; Girault et al., 2007).
Prior work has implicated ERK activity in striatally mediated
locomotor and adaptive behaviors, but these studies have pro-
duced conflicting results (Girault et al., 2007; Cerovic et al., 2013;
Calabresi et al., 2014). Pharmacological inhibition of ERK signal-
ing prevented consolidation ofmotor skill learning, instrumental
learning, and habit formation (Bureau et al., 2010; Shiflett et al.,
2010; Shiflett and Balleine, 2011). In contrast, loss of ERK1 in
germline knock-out mice showed surprising effects, including
baseline hyperactivity, increased synaptic plasticity, enhanced
learning, and enhanced locomotor response to cocaine (Selcher
et al., 2001; Mazzucchelli et al., 2002; Ferguson et al., 2006; Engel
et al., 2009). This disparity has been attributed to increased ERK2
function in ERK1-deleted animals, emphasizing the need to de-
lete both ERK1 and ERK2 in genetic studies (Mazzucchelli et al.,
2002; Ferguson et al., 2006). Moreover, prior genetic and phar-
macological studies have failed to target ERK inhibition to spe-
cific striatal cell types, further confounding interpretations of
ERK function. Therefore, despite the evidence supporting the
importance of ERK signaling to striatal functions and adapta-
tions, pathway-specific functions of ERK signaling have not been
identified (Fasano and Brambilla, 2011).
Here, we have delineated cell-type-specific functions of ERK
signaling by conditionally deleting ERK2 on an ERK1-null back-
ground using D1-Cre and D2-Cre lines (Gong et al., 2007). Loss
of ERK inD1R-MSNs led to decreased locomotor activity, failure
to thrive, and early postnatal lethality, precluding further analysis
of the mice. Deletion of ERK in D2R-MSNs resulted in a hyper-
locomotor phenotype that is comparable to D2-specific cell ab-
lation studies reported previously (Durieux et al., 2009). We
report, for the first time, physiological analysis of D2R-MSNs in
the setting of complete ERK deletion. ERK-deleted D2R-MSNs
are remarkably hypoexcitable, showing reduced frequencies of
postsynaptic currents andmajor reductions in intrinsic excitability.
Finally, expression of immediate early and plasticity-associated
genes are markedly reduced in ERK-deleted D2R-MSNs both at
baseline and in response to pharmacological stimulation. We
conclude that ERK signaling is required for pathway-specific stri-
atal motor functions. Furthermore, ERK signaling is essential to
the excitability and activity-regulated gene expression of D2R-
MSNs.
Materials andMethods
Animals. Animals were used and maintained in accordance with the
National Institutes of Health’s Guide for the Care and Use of Laboratory
Animals and all protocols were approved by the Institutional Animal
Care and Use Committee at the University of North Carolina-Chapel
Hill (UNC). Drd2-EGFP, Drd1a(EY262)-Cre, Drd2(EY43)-Cre, and
Adora2a-Cre mice were purchased from the Mutant Mouse Regional
Resource Center (MMRRC) (Gong et al., 2007). Erk1 / (Mapk3 /)
and Erk2 loxP/loxP (Mapk1 loxP/loxP) mice (Nekrasova et al., 2005; Samuels
et al., 2008) were kindly provided by G. Landreth (CaseWestern Reserve
University, Cleveland, OH).Drd1a tdTomato (Ade et al., 2011), Ai3-EYFP,
and Ai9-tdTomato (Madisen et al., 2010) reporter lines were purchased
from The Jackson Laboratory. All animals were maintained on a
C57BL/6J background. For birth-dating, the day of birth was recorded as
postnatal day 0 (P0). All experiments were replicated independently with
a minimum of three animals per condition. Power analysis was con-
ducted on preliminary samples to determine sample size using StatMate
software (GraphPad). We chose a significance  value of 0.05 and a
power value of 0.8. Mixed-sex samples were used for analyses unless
otherwise noted. For all experiments, Erk1 /;Erk2 loxP/loxP littermate
controls were used for comparison unless otherwise specified. For geno-
typing, DNAwas extracted from tail or toe samples and PCR analysis was
conducted using standard techniques. Genotyping primer sequences
were as follows: D1-Cre: Fwd-5-GCTATGGAGATGCTCCTGATGG
AA-3, Rev-5-CGGCAAACGGACAGAAGCATT-3; D2-Cre: Fwd-5-
GTGCGTCAGCATTTGGAGCAA-3, Rev-5-CGGCAAACGGACAGA
AGCATT-3; Adora2a-Cre: Fwd-5-CGTGAGAAAGCCTTTGGGAA
GCT-3, Rev-5-CGGCAAACGGACAGAAGCATT-3; D2-GFP: Fwd-
5-GAGGAAGCATGCCTTGAAAA-3, Rev-5-TGGTGCAGATGAAC
TTCAGG-3; ERK1 KO: Fwd-5-AAGCAAGGCTAAGCCGTACC-3,
Rev (WT)-5-AAGGTTAACATCCGGTCCAGCA-3, Rev(Mut)-5-CA
TGCTCCAGACTGCCTTGG-3; ERK2 Flox: Fwd-5-AGCCAACAATC
CCAAACCTG-3, Rev-5-GGCTGCAACCATCTCACAAT-3; Ai3:
Fwd(WT)-5-AAGGGAGCTGCAGTGGAGTA-3, Rev(WT)-5-CCG
AAAATCTGTGGGAAGTC-3, Fwd (Mut)-5-ACATGGTCCTGCTG
GAGTTC-3, Rev(Mut)-5-GGCATTAAAGCAGCGTATCC-3; Ai9:
Fwd(WT)-5-AAGGGAGCTGCAGTGGAGTA-3; Rev(WT)-5-CCGA
AAATCTGTGGGAAGTC-3, Fwd (Mut)-5-GGCATTAAAGCAGCG
TATCC-3, Rev(Mut)-5-CTGTTCCTGTACGGCATGG; D1 tdTomato:
Fwd-5-CTTCTGAGGCGGAAAGAACC-3, Rev-5-TTTCTGATTGA
GAGCATTCG.
Acute tissue extraction.Mice were killed via cervical dislocation and the
brains immediately extracted and rinsed in ice-cold 1 PBS. The brains
were then placed in a chilled acrylic brain matrix (Ted Pella) and 1-mm-
thick coronal slicesweremadeusing a razor blade. Sliceswere thenplaced
in chilled 1 PBS and, using a 1 mmmicropunch (Ted Pella), 2–3 tissue
punches were extracted from dorsal striatum from each hemisphere for
analysis using gene expression profiling (see below).
Gene expression profiling. Striatal punches were extracted from three
littermate control and three mutant P17male mice generated from three
independent litters. Total RNA was extracted using TRIzol reagent
(Invitrogen), followed by mRNA extraction using an RNeasy Mini Kit
(Qiagen) according to the manufacturer’s instructions. Quantity of ex-
tracted mRNA was analyzed using a Nanodrop (ND1000) spectropho-
tometer and the quality was verified with an Agilent Technologies 2100
Bioanalyzer. The RNA was then amplified, labeled, and hybridized to an
Affymetrix Clariom D Array in the UNC Functional Genomics Core
using the manufacturer’s protocol. Gene-level differential expression
analysis was conducted using Transcriptome Analysis Console version
3.0 (Affymetrix)with the default algorithmparameters for theClariomD
Array. Log2 sample values were used to determine differential gene ex-
pression and p-values. Genes were considered upregulated or downregu-
lated if there was a 1.5-fold difference in expression levels compared
with control samples. Changes were considered significant at p  0.05.
The data discussed herein have been deposited in NCBI’s Gene Expres-
sion Omnibus (Edgar et al., 2002) and are accessible through GEO Series
accession numberGSE93844 (https://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?accGSE93844).
Tissue fixation and preparation. Mice were anesthetized with a 2.5%
Avertin solution (Sigma-Aldrich) and then transcardially perfused with
4% paraformaldehyde/PBS (Sigma-Aldrich). Brains were then postfixed
in 4% paraformaldehyde solution at 4°C overnight. Tissue was mounted
in 4% low-melt agarose and 80 m coronal or sagittal sections were
generated using a vibratome (Leica).
Immunohistochemistry. Brain sections were rinsed in 1 PBS and then
blocked with 5% normal donkey serum/0.1% Triton X-100 in 1 PBS
(PBS-T) for 1 h at room temperature. Sections were then incubated in
primary antibody in PBS-T for 48 h at 4°C with slight agitation. After
primary incubation, slices were rinsed with PBS-T and then incubated in
fluorescent secondary antibodies in PBS-T for 24 h at 4°C. Sections were
again rinsed with PBS-T and then mounted on Superfrost/Plus slides
(Fisher Scientific) using Prolong Diamond Mountant (Life Technolo-
gies) before coverslipping.
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Antibodies. Primary antibodies used for Western blot were rabbit
phospho-MAPK1/3(ERK1/2) (Thr202/Tyr204) and rabbit MAPK1/
3(ERK1/2) (Cell Signaling Technology). Primary antibodies used for im-
munohistochemistry were as follows: rabbit Erk2 and rat Ctip2 (1:500,
Abcam), rabbit c-FOS (1:500; Cell Signaling Technology), chicken GFP
(1:1000; Aves Laboratories), rabbit RFP and mouse RFP (1:250; Rock-
land), and rabbit ARC (1:1000; Synaptic Systems). Secondary antibodies
used: goat/chicken/donkey Alexa Fluor 488, goat/donkey Alexa Fluor
568, and goat/donkey Alexa Fluor 647 (1:1000; Life Technologies).
Viral injections.P1micewere individually cryo-anesthetized onwet ice
for 3 min and then immediately injected with 200 nl of virus solution
using a 5 l Hamilton syringe fitted with a 32 gauge beveled needle
mounted to a stereotaxic arm. AAV8-CAG-GFP (UNC Vector Core,
Chapel Hill, NC) virus was prepared by diluting concentrated virus with
PBS  5% sorbitol  0.1% Fast Green (for visualization) for a final
concentration of 5 108 molecules/l. Unilateral injections were made
into the striatum. After the injection, pups were placed on a heating pad
until they recovered. Upon recovering, all pups were then placed back
into their home cage.
Locomotor activity. Naive animals were evaluated for spontaneous lo-
comotor activity using a 45 45 cm Plexiglass arena and Ethovision XT
11.5 (Noldus) video-tracking software. Distance traveled was measured
using Lowess smoothing to minimize tracking fluctuations. All animals
were acclimated to the testing room 3 h before locomotor testing.
Catalepsy. Two-month-old mice were injected with 1 mg/kg haloper-
idol (0.1 mg/ml) 1 h before evaluation of cataleptic behavior. To test
catalepsy, both front pawswere placed on a horizontal barmounted 4 cm
above the testing chamber floor while both hindpaws remained on the
floor. The time taken to remove both forepaws from the bar or move
both paws sideways on the bar was recorded. Maximum trial times were
300 s. Mice were tested in three consecutive trials unless the maximum
cutoff timewas achieved in one of the trials. Catalepsywas determined by
taking the average of the three trials or 300 s if the maximum was
achieved. Haloperidol bromide (Sigma-Aldrich) stock solution was dis-
solved in (25 l of glacial acetic acid diluted to 1 mg/ml with 0.9% saline
and buffered to pH 6.5 with 1 N NaOH). Stock solution was then diluted
with 0.9% saline to generate a 0.1 mg/ml working solution. Injection
vehicle solution was generated in the same manner without the addition
of haloperidol.
Imaging. All images were acquired using a model 780 confocal micro-
scope with ZEN 2011 software (both Carl Zeiss). For comparative stud-
ies, image acquisition settings were maintained across all samples. For
dendritic spine analysis, five D1R-MSNs and five D2R-MSNs were ana-
lyzed per animal from the dorsal striatum. Labeled MSNs were selected
randomly for analysis from a group that showed no dendritic overlap
with neighboring GFP-labeled cells. Three secondary or tertiary den-
drites were then analyzed per cell. For best resolution, only dendrites that
were located between 5 and 20 m from the slice surface and that dis-
played minimal variation in the horizontal plane were analyzed. All im-
aged dendrites could be traced continuously back to their respective
soma. 3D 42.5  42.5 m z-stack images of dendritic segments were
acquired using 0.388moptical sections. After acquisition, images were
coded and analysis was conducted by a blinded observer. 3D reconstruc-
tion and spine quantification were conducted using Neurolucida 10
software (MBF Bioscience). Dendritic spines were traced manually
throughout each 3D reconstruction image and quantified automatically
by the software program.
Cell quantification. Cell quantification was performed on 637  637
m RGB images acquired from anatomically matched slices of dorsal
striatum.All image analysiswas conductedby anobserver blinded to sample
genotypesusingPhotoshopCS3 software (Adobe).TheD1 tdTomato fluores-
cent reporter was used to identify D1R-MSNs (red fluorescence) and
D2R-MSNs (no fluorescence). For each image, all CTIP2-positive MSNs
were counted. For the assessment of c-FOS- and ARC-expressing cells,
individual MSNs were first selected based upon Ctip2 (blue channel)
labeling using the “quick selection tool.” Next, each selected cell was then
categorized as a D1R-MSN or D2R-MSN based upon whether it ex-
pressed D1 tdTomato fluorescence (red channel). Last, c-FOS or ARC
(green channel) was selected and the integrated pixel intensity and area
for each cell was recorded automatically by the software. The average
pixel density (pixel intensity/area) was calculated for each selected cell. A
cell was considered positive for c-FOS or ARC expression if the average
pixel density was 2-fold higher than background. The assessment of
ERK2 expression was performed similarly except that ERK2 expression
was determined manually by the observer. For analysis of D2GFP-
A2aCre;Ai9 experiments, D2GFP, A2aCre;Ai9, and colabeled cells were
counted manually using the count tool in Photoshop.
Patch-clamp electrophysiology. For all electrophysiology analyses, the
experimenter was blinded to sample genotypes. Mice were anesthetized
with pentobarbital and transcardial perfusions were performed using an
ice-cold sucrose cutting solution (0–1°C) containing the following (in
mM): 225 sucrose, 119 NaCl, 1.0 NaH2PO4, 4.9 MgCl2, 0.1 CaCl2, 26.2
NaHCO3, and 1.25 glucose, 305–308 mOsm. Brains were then removed
and submerged in the cutting solution and 300-m-thick coronal sec-
tions were made using a vibrating blade (Leica, VT 1200). Slices were
then placed in warm aCSF (32°C) containing the following (in mM): 119
NaCl, 2.5 KCl, 1.0 NaH2PO4, 1.3MgCl, 2.5 CaCl2, 26.2 NaHCO3, and 15
glucose, 305 mOsm. After at least 1 h of recovery, slices were perfused
with warm aCSF (32°C) containing no pharmacology (excitability re-
cordings) or with 0.5 M tetrodotoxin [miniature EPSC (mEPSC) and
miniature IPSC (mIPSC) recordings; Sigma-Aldrich]. Neurons were vi-
sualized using differential interference contrast through an upright 40
water-immersion objective mounted to an upright microscope (Olym-
pus BX51WI). Fluorescent imaging using a mercury lamp (Olympus
U-RFL-T) was used to identify tdTomato-positive (D1) versus tdTomato-
negative (D2) MSNs.
Synaptic connectivity was measured through mEPSC and mIPSC
recordings obtained using glass electrodes (3–5 	
) back-filled with
cesium methylsulfonate internal solution containing the following (in
mM): 117 Cs methanesulfonic acid, 20 HEPES, 2.8 NaCl, 5 TEA, 2 ATP,
and 0.2 GTP, pH 7.35, mOsm 280. mEPSCs were obtained by holding
neurons at 70 mV for 5 min and mIPSCs were obtained by holding
neurons at10mV for 5min. Data acquisition formEPSCs andmIPSCs
occurred at 1 kHz sampling rate through a MultiClamp 700B amplifier
connected to a Digidata 1440A digitizer (Molecular Devices).
Excitability recordings were obtained using glass electrodes (3–5	
)
back-filled with a potassium gluconate internal solution containing the
following (inmM): 130 K gluconate, 10 KCl, 10HEPES, 10 EGTA, 2MgCl2,
2 ATP, and 0.2 GTP, 280 mOsm. Intrinsic neuronal excitability was evalu-
atedbydepolarizing eachneuronusing800mscurrent steps (0 to500pA; 50
pAsteps).Rheobasewasalso evaluatedbydepolarizingeachneuron in50ms
current steps (0 to 1000 pA; 10 pA steps). Data acquisition for excitability
recordings occurred at a 10 kHz sampling rate. Excitability data were ana-
lyzed using a threshold analysis (Clampfit 10.3).
Statistical analysis.All data were analyzed using Prism version 6.0 soft-
ware (GraphPad). Data are presented as mean SEM unless otherwise
noted. For direct comparisons, statistical significance was determined
using a two-tailed t test with Welch’s correction. For studies requiring
ANOVA, methods used for post hoc analysis to determine statistical sig-
nificance are mentioned in the text and figure legends.
Results
Cell-type-specific deletion of ERK in D1R- and D2R-MSNs
ERK signaling has been proposed to be a key integrator of dopa-
minergic and glutamatergic input ontoMSNs and a critical mod-
ulator of neuronal plasticity (Girault et al., 2007; Fasano and
Brambilla, 2011). To understand the functional role of ERK sig-
naling in the striatum, we generated mutant mice in which Erk1
and Erk2 genes were deleted in specific populations of MSNs.
Both genes require deletion due to functional redundancybetween
ERK1 and ERK2 (Selcher et al., 2001; Mazzucchelli et al., 2002). To
accomplish cell-type-specific deletion, we crossed Erk1 /
Erk2 loxP/loxP mice (Nekrasova et al., 2005; Samuels et al., 2008)
with the well documented D1-Cre and D2-Cre lines (Gong et al.,
2007). The resulting Erk1 /Erk2 loxP/loxP:D1Cre (ERK:D1) and
Erk1 /Erk2 loxP/loxP:D2Cre (ERK:D2) lines were germline null for
ERK1 and lacked ERK2 expression in D1R-MSNs and D2R-
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MSNs, respectively. Littermate Erk1 /Erk2 loxP/loxP mice were
also germline null for ERK1 andwere used as controls for all stud-
ies unless otherwise noted. Because bothD1 andD2 receptors are
expressed in other brain regions (Gong et al., 2007),we cannot fully
exclude thepossibilityofnonstriatal contributions to the strongphe-
notypes that we describe below.
To verify that ERK2 was specifically ablated in D1R-MSNs
and D2R-MSNs of ERK:D1 and ERK:D2 animals, respectively,
we analyzed the cell-type-specific expression of ERK2 at P21 us-
ing immunohistochemistry. To distinguish between MSN sub-
types, both the ERK:D1 and ERK:D2 lines
were crossed with the D1tdTomato reporter
mouse line (Ade et al., 2011). Expression
of tdTomato red fluorescent protein ex-
clusively in D1R-MSNs allowed us to
distinguish between D1R-MSNs (red fluo-
rescence) and D2R-MSNs (no fluores-
cence). In ERK:D1 animals, only 3% of
D1R-MSNs expressed ERK2 compared
with control littermates (Welch-corrected
t(2.16)  84.77, p  0.0001; Fig. 1A). We
observed a similar reduction in ERK2 ex-
pression in D2R-MSNs of ERK:D2 mu-
tant mice (Welch-corrected t(2.95) 
40.64, p  0.0001; Fig. 1B). Our findings
demonstrate that ERK activity is ablated
in distinct MSN populations of ERK:D1
and ERK:D2 mutant mice.
ERK signaling has been implicated pre-
viously in cellular growth and maintenance
(Cargnello and Roux, 2011). To assess the
integrity of the ERK-deficient MSN axonal
projections, we crossed ERK:D1 and
ERK:D2 mice with the Ai3 reporter line,
which conditionally expresses enhanced
yellow fluorescent protein in a Cre-
dependent manner (Madisen et al., 2010).
D1R-MSN projections to the GPi and SNr
appeared intact in ERK:D1 mutant mice
compared with littermate controls (Fig.
1C,D, P21). Similarly, D2R-MSN projec-
tions to theGPe also appeared unaffected in
ERK:D2 animals (Fig. 1E,F, P21). More-
over, we assessed MSN subtype survival at
P21 by comparing the percentages of D1R-
MSNandD2R-MSNcells in both ERK:D1
and ERK:D2 mice relative to littermate
controls. For ERK:D1 mice (n  3 mice/
genotypes), we did not observe a signifi-
cant difference in the percentage of D1R-
MSNs (53.1% 1.38 for control vs 52.3
0.94% for ERK:D1, Welch-corrected
t(3.52)  0.51, p  0.64) or D2R-MSNs
(47.4 0.69% for control vs 47.3 0.57%
for ERK:D1,Welch-corrected t(3.83) 0.13,
p  0.90) compared with control litter-
mates. Similarly, we did not observe any
significant changes in the percentage of
D1R-MSNs (51.6  0.73% for control vs
50.62.53%forERK:D2,Welch-corrected
t(2.34)  0.37, p  0.75) or D2R-MSNs
(48.5 0.73% for control vs 49.4 2.53%
for ERK:D2,Welch-corrected t(2.33) 0.37,
p 0.74) in ERK:D2 mice relative to litter-
mate controls (n3mice/genotype).These results suggest thatERK
activity is not necessary for the targeting or maintenance of D1R-
MSNorD2R-MSNprojections. However, we cannot excludemod-
est effects on axon branching or synaptogenesis.
Both ERK:D1 and ERK:D2mice were generated in the appro-
priate Mendelian ratios. However, we observed a significant re-
duction in weight gain between P7 and P19 in ERK:D1 mutants
compared with littermate controls (repeated-measures ANOVA;
main genotype effect, F(1,5) 91.90, p 0.0002; main time effect
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Figure 1. ERK-deficient MSNs show proper targeting of axonal projections. A, Quantification of the relative percentage of
ERK2-positive D1R-MSNs in control and ERK:D1 mutant mice at P21. ERK2 (green) is coexpressed with D1 tdTomato (red) in D1R-
MSNs of littermate control mice, but is lost in virtually all D1R-MSNs of ERK:D1 mutant mice (*p 0.001; n 3 mice/genotype,
150 cells/mouse). Scale bar, 50 m. B, Quantification of the percentage of ERK2-postive D2R-MSNs in littermate control and
ERK:D2 mutant mice at P21. ERK2 (green) is expressed in in both D1 tdTomato-positive D1R-MSNs and D1 tdTomato-negative D2R-
MSNs of littermate controlmice, but is lost in virtually all D1 tdTomato-negativeD2R-MSNs of ERK:D2mutantmice (*p0.001;n
3 mice/genotype, 150 cells/mouse). Scale bar, 50 m. C, D, Control (ERK/;ERK2w/w:D1 Cre) and ERK:D1 mutant mice were
backcrossedwith Cre-dependent fluorescent reporter Ai3mice to label all D1R-MSN projectionswith enhanced yellow fluorescent
protein (eYFP). Normal D1R axon targeting to the GPi and SNr is observed in control (C) and ERK:D1 mutant (D) mice. Scale bar,
1mm. E, F, Control (ERK/;ERK2w/w:D2 Cre) and ERK:D2mutantmice were backcrossedwith Ai3mice to label D2R-MSN axonal
projections with eYFP. Normal D2R axon targeting to the GPe is observed in control (E) and ERK:D2 mutant (F ) mice. Insets show
magnified images of GPe. Scale bar, 1mm.G, Quantification ofweight gain during the second and third postnatalweeks in ERK:D1
mutant mice compared with ERK/;ERK2 Fl/Fl littermate controls. ERK:D1 animals show significant deficits in weight gain
beginning at P7 and continuing through P19 (n 6 animals/genotype, main effect for genotype F(1,10) 84.96, *p 0.0001,
Bonferroni post hoc comparison).H, Kaplan–Meier survival curve of ERK:D1 (blue line, n 80mice) and ERK:D2 (green line; n
71mice) mice compared with ERK1/;ERK2 Fl/Fl controls (black line, n 57mice). ERK:D1mice show a significant reduction in
survival (*p 0.0001, post hoc Gehan–Breslow–Wilcoxon test). All data are presented as mean SEM.
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F(6,30) 494.1, p 0.0001, time genotype interaction: F(6,30)
59.92, p 0.0001; Fig. 1G) and a significant decrease in survival
beginning at 3 weeks of age (median age of death 28 d; Gehan-
Breslow-Wilcoxon survival test: (1)
2  60.72, p  0.0001; Fig.
1H). In contrast, ERK:D2 mice survived normally compared
with littermate controls (Gehan–Breslow–Wilcoxon survival
test: (1)
2  0.065, p 0.799; Fig. 1H).
ERK signaling is required for pathway-specific regulation of
locomotor behavior
Previous studies using genetic cell ablation or optogenetic ma-
nipulation have shown that D1R-MSN loss or inhibition dramat-
ically reduces locomotor activity (Drago et al., 1998; Kravitz et al.,
2010; Durieux et al., 2012), whereas ablation or optogenetic si-
lencing of D2R-MSNs increases locomotion (Durieux et al.,
2009; Kravitz et al., 2010). To determinewhether ERK signaling is
essential for pathway-specific locomotor function, we assessed
basal locomotor activity in naive ERK:D1 and ERK:D2mice using a
30 min open-field assay. Analysis of ERK:D1 mice at P21 showed a
significant decrease in activity compared with littermate controls,
demonstrating that ERK activity in D1R-MSNs is necessary for fa-
cilitating locomotor behavior (Welch-corrected t(10.98) 3.80, p
0.003; Fig. 2A,B). However, the rapid decline in health of ERK:D1
mutant mice precluded us from pursuing more detailed analyses of
this line becausewe couldnot properly control for potential second-
ary health effects on D1R-MSN functions.
In contrast, ERK:D2 mutant mice showed a significant in-
crease in total distance traveled compared with littermate con-
trols (Welch-corrected t(10.8) 4.93, p 0.0005; Fig. 2C,D). To
assess potential sexual dimorphism, we also compared open-field
activity between male and female ERK:D2 mice, but found no
significant differences (14.2 m  2.08 male vs 15.5 m  2.09
female; post hoc Welch-corrected t(7.5)  0.42, p  0.68, n  4
male mice, 6 female mice). To investigate whether ERK:D2 mice
eventually acclimate to the testing arena and reduce their basal
activity, we also analyzed the mice in a 3 h open-field assay. Lo-
comotor activity in control animals decreased steadily through-
out the trial. In contrast, ERK:D2mutantmicemaintained a high
level of activity throughout the 3 h testing period (repeated-
measures ANOVA: main genotype effect: F(1,9)  31.70, p 
0.0003; time genotype interaction: F(17,153) 4.73, p 0.0001;
Fig. 2E). These results demonstrate that ERK activity is required
for the proper function of D2R-MSNs in suppressing locomotor
behavior.
Reduced dendritic spine formation and activity-induced gene
expression in ERK-deficient D2R-MSNs
Pharmacological blockade of ERK activity prevents stimulation-
induced dendritic spine formation in ex vivo slice systems (Gol-
din and Segal, 2003; Alonso et al., 2004). However, it is unclear
whether ERK is required for spinogenesis during normal striatal
development. To determine whether dendritic spines are altered
in ERK-deficient D2R-MSNs, we labeled sparse populations of
MSNs by injecting anAAV8-CAG-GFP virus unilaterally into the
striatum of ERK:D2 and littermate control P1 neonatal animals.
We then killed the mice at P21, a period during which active
synaptogenesis is occurring in the striatum (Tepper et al., 1998;
Goldin and Segal, 2003; Alonso et al., 2004; Kozorovitskiy et al.,
2012). AAV8-CAG-GFP brightly labels the entire MSN, includ-
ing dendritic spines, which were then imaged using 3D confocal
microscopy. To distinguish between D1R-MSN andD2R-MSNs,
we backcrossed the ERK:D2 line with the D1tdTomato (D1tdT)
reporter line, which expresses tdTomato red fluorescent protein
exclusively in D1R-MSNs (Ade et al., 2011). Therefore, all cells
that coexpressed GFP and tdTomato were identified as D1R-
MSNs, whereas cells that expressed GFP only were identified as
D2R-MSNs (Fig. 3A).
At P21, a significant reduction in the density of spines was
observed along dendrites of D2R-MSNs in ERK:D2 mice com-
pared with littermate controls (Welch-corrected t(2.148) 6.190,
p 0.0211; Fig. 3B,C). The effect wasmore prominent for thinner
spines normally associated with plasticity than for thicker, broader
spines. Interestingly,wedidnot observe a significant change in spine
density along dendrites of D1R-MSNs in ERK:D2 animals (Welch-
corrected t(2.444) 0.5122, p 0.6511; Fig. 3B,C).
In addition to changes in dendritic spines, we also observed
a reduction in soma size in ERK-deficient MSNs. Quantitative
analysis demonstrated that D2R-MSNs showed a significant re-
duction in somal area in ERK:D2 animals compared with litter-
mate control mice (control  138.1 m2  1.855; ERK:D2 
113.6 m2 2.034; Welch-corrected t(5.95) 8.893, p 0.0001;
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Figure 2. ERK signaling is required for pathway-specific regulation of locomotor behavior.
A, Quantification of total distance traveled in a 30 min testing period by ERK:D1 (blue bar) and
paired littermate control (gray bar)mice at P21. ERK:D1 animals show a significant reduction in
locomotor activity (*p 0.01, n 10 mice/genotype). B, Representative recordings of total
distance traveled (30 min) in control and ERK:D1 animals. C, Quantification of total distance
traveled in a 30 min testing period by ERK:D2 mutant mice (green bar) and paired littermate
controls (gray bar). ERK:D2 mutants show significantly more locomotor activity than controls
(*p 0.001, n 10mice/genotype).D, Representative tracks of cumulative open-field activ-
ity for control and ERK:D2 mutant mice. E, Three hour open-field analysis of ERK:D2 mice and
controls. Shown is total distance traveled as a function of time. ERK:D2 mutant mice (green
trace) showed significantly increasedmovement throughout the entire 3 h testing period com-
pared with control animals (gray trace), which steadily reduce activity throughout the trial
(*p 0.001; n 10 mice/genotype). All data are presented as mean SEM.
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n 4mice/genotype, 5 cells/mouse). These results are consistent
with previous reports of reduced soma diameter inD2R-MSNs of
conditional BDNF-TrkB knock-out mice (Li et al., 2012).
Defects in spinogenesis might be expected to lead to reduc-
tions in activity-regulated transcripts and in abnormal physiolog-
ical function (see below). To investigate the transcriptional
changes that occur in ERK-deleted D2R-MSNs during the period
of active striatal synaptogenesis, we performed microarray anal-
ysis on striatal punches from littermate control and ERK:D2mice
at P17 (Tepper et al., 1998; Goldin and Segal, 2003; Kozorovitskiy
et al., 2012). We observed a significant reduction in the expres-
sion of a number of critical immediate early genes (IEGs); Egr1,
Egr2, Egr4, Fosl2, and Srf levels were all significantly reduced in
ERK:D2mice (Fig. 3D). These reductions are consistent with the
idea that ERK-deficient D2-MSNs are severely impaired in their
ability to respond to presynaptic stimuli (Okuno, 2011).
We also identified a number of genes associated with synapse
formation and plasticity that show significantly downregulated
expression in ERK:D2 mutant mice (Fig. 3E). We observed
significantly reduced expression of the postsynaptic genes Arc,
Homer1, andNptx2; the G-protein signaling regulatorRgs2; and the
transcriptional activatorNr4a1 (West andGreenberg, 2011; Chen et
al., 2014). Together, our results related to spinogenesis and activity-
regulated gene expression suggest that ERK activity is necessary for
proper synaptic function and downstream signaling events.
Reduced synaptic drive and intrinsic excitability in
ERK-deleted D2R-MSNs
Our findings that ERK:D2 mice have increased locomotor activ-
ity logically raise the question of whether electrophysiological
properties of D2R-MSNsmay also be affected. To test this, patch-
clamp electrophysiological recordings were obtained ex vivo to
identify the strength of excitatory and inhibitory synaptic input
to D2R-MSNs in ERK:D2 and control littermates (Fig. 4A). Re-
cordings of mEPSCs (Fig. 4B,C) revealed a reduction in the fre-
quency (t(16) 3.32; p 0.004), but not amplitude (t(16) 1.74;
p  0.101), of D2R-MSN mEPSCs in ERK:D2 mutant (black
trace) versus control mice (gray trace). Recordings of mIPSCs
(Fig. 4D,E) revealed a reduction in both frequency (t(15) 3.13;
p 0.007) and amplitude (t(15) 3.10; p 0.007) of D2R-MSN
mIPSCs in ERK:D2 mice (black trace) versus control mice (gray
trace). Together, these data reveal a reduction in both excitatory
and inhibitory synaptic drive onto D2R-MSNs in ERK:D2 mice.
Next, we obtained ex vivo patch-clamp electrophysiological
recordings to identify the strength of excitatory and inhibitory
synaptic input to D1R-MSNs (Fig. 4F) in ERK:D2 mutant and
control animals. Recordings of mEPSCs (Fig. 4G,H) revealed no
change in the frequency (t(13)1.43; p 0.178) or amplitude (t(13)
 0.95; p 0.359) of D1R-MSNmEPSCs in ERK:D2mice (black
trace) versus control mice (red trace). Similarly, recordings of
mIPSCs (Fig. 4 I, J) revealed no change in the frequency (t(13) 
p<0.05
Gene Anova p-Value
Fold Change 
(Compared to Control)
Arc 0.011947 -2.85
Nr4a1 0.00621 -2.44
Rgs2 0.001251 -1.72
Homer1 0.009969 -1.42
Nptx2 0.006279 -1.36
Synaptic Plasticity Associated Genes
Gene Anova p-Value
Fold Change 
(Compared to Control)
Egr1 0.005808 -2.1
Egr2 0.000953 -1.96
Fos 0.079076 -1.91
Fosl2 0.032868 -1.78
Egr3 0.069367 -1.74
Egr4 0.002845 -1.51
Fosb 0.067583 -1.38
Klf10 0.052887 -1.37
Srf 0.011213 -1.36
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1.97; p  0.070) or amplitude (t(13) 
1.18; p  0.260) of D1R-MSN mIPSCs in
ERK:D2 mice (black trace) versus control
mice (red trace). These results suggest that
loss of ERK activity in D2R-MSNs does
not alter synaptic drive significantly in
D1R-MSNs.
In addition to changes in synaptic ac-
tivity, alterations in the intrinsic excitabil-
ity of neurons can lead tomodifications in
the activity of neural networks. Therefore,
we evaluated the intrinsic excitability of
D2R-MSNs in ERK:D2 and control mice.
Overall, we found that the intrinsic excit-
ability of D2R-MSNs in ERK:D2 mice
(black trace) was reduced compared with
control mice (gray trace) (Fig. 4K,L).
Two-way ANOVA revealed a significant
interaction (F(10,170) 4.417, p 0.0001)
and planned comparisons revealed that
the maximum number of action poten-
tials for any sweep was lower in neurons
from ERK:D2 mice versus control mice
(Table 1). Furthermore, this reduction in
action potential frequency in ERK:D2
mice was likely attributable to a reduced
capacity to initiate action potentials be-
cause both rheobase and action potential
amplitude were reduced (Table 1). Fi-
nally, we performed intrinsic excitability
recordings in D1R-MSNs from ERK:D2
and control mice. Overall, we found that
the intrinsic excitability of D1R-MSNs in
ERK:D2 mice (black trace) was slightly
reduced compared with that of control
mice (red trace) (Fig. 4M,N). Two-way
ANOVA revealed a significant interaction
(F(10,160)  2.93; p  0.002), although
planned comparisons revealed no differ-
ences in the maximum number of action
potentials for any sweep, rheobase, or ac-
tion potential amplitude (Table 1). These
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tative mIPSC recordings of D1R-MSNs from control (red) and ERK:D2 mutant (black) mice. J, Summary of mIPSC
4
frequencies and amplitudes from control (red; n 3 mice;
n 8 neurons) and ERK:D2mutant (black; n 3mice; n 7
neurons) D1R-MSNs. There is no significant difference be-
tween ERK:D2 mutant D1R-MSNs and control MSNs.
K, Representative traces of whole-cell patch-clamp recordings
from D2R-MSNs in control (gray) and ERK:D2 mutant (black)
mice. L, Relationship between elicited action potential re-
sponses and somatic current injection in D2R-MSNs of control
(gray; n 3mice; n 9 neurons) and ERK:D2mutant (black;
n 3 mice; n 10 neurons) mice. D2R-MSNs from ERK:D2
mutant mice have a significantly reduced capacity to elicit ac-
tion potentials (*p  0.001). M, Representative traces of
whole-cell patch-clamp recordings from D1R-MSNs in control
(red) and ERK:D2 mutant (black) mice. N, Relationship be-
tween elicited action potential responses and somatic current
injection in D1R-MSNs of control (red; n  3 mice; n  9
neurons) and ERK:D2 mutant (black; n 3 mice; n 9 neu-
rons) mice. Intrinsic excitability in D1R-MSNs of ERK:D2 mu-
tant mice was slightly, but significantly, reduced compared
with controls (*p 0.01).
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data demonstrate that ERK-deficient D2R-MSNs have a signifi-
cantly reduced capacity to fire action potentials.
Activity-regulated gene expression is strongly suppressed in
ERK-deleted D2R-MSNs
InD2R-MSNs, dopamine binding toD2R/Gi-coupled receptors
represses neuronal excitability (Surmeier et al., 2007), whereas
D2R antagonists, including haloperidol, derepress the cell and
allow it to respond to excitatory input (Bonito-Oliva et al., 2011).
In mice, haloperidol administration has been shown to induce
catalepsy (Sanberg, 1980; Farde et al., 1992), an effect associated
with increased phosphorylated ERK activity in D2R-MSNs
(Bertran-Gonzalez et al., 2008). To determine whether D2R-
MSN-specific ERK activity is necessary for cataleptic behavior,
we administered haloperidol (1 mg/kg, i.p.) or vehicle to adult
ERK:D2mutants and littermate controls and tested for cataleptic
response 1 h after administration using the horizontal bar test
(Fig. 5A). Two-way ANOVA revealed a significant difference be-
tween genotypes (F(1,24) 149.0, p 0.0001), treatment (F(1,24)
118.9, p  0.0001), and a genotype  treatment interaction
(F(1,24)  114.3, p  0.0001). Haloperidol administration led to
an extended cataleptic freezing response in control mice com-
pared with vehicle-treated controls (vehicle control vs haloperi-
dol control Tukey’s post hoc adjusted: p  0.0001; Fig. 5B).
Strikingly, haloperidol-treated ERK:D2 littermates were insensi-
tive to these cataleptic effects (haloperidol control vs haloperidol
ERK:D2 Tukey’s post hoc adjusted: p  0.0001; Fig. 5B). These
findings demonstrate that ERK activity in D2R-MSNs is neces-
sary for the induction of haloperidol-induced catalepsy in mice.
In addition to cataleptic behavior, haloperidol administration
has also been demonstrated to strongly enhance activity-regulated
gene expression in the striatum (Robertson et al., 1992). c-FOS is a
well documented activity-induced gene and has been shown to be
upregulated selectively in D2R-MSNs after acute haloperidol ad-
ministration (Bertran-Gonzalez et al., 2008). We therefore ana-
lyzed cell-specific c-FOS expression in ERK-deleted and control
D2R-MSNs after haloperidol or vehicle administration. To dis-
tinguish between D1R-MSN and D2R-MSNs, we again used the
D1tdT mouse line to identify D1R-MSNs (see above). We also
colabeled with the ubiquitous MSN marker CTIP2 to exclude
non-MSN cells from analysis (Arlotta et al., 2008). CTIP2-
positive neurons that expressed tdTomatowere identifiedasD1R-
MSNs, whereas CTIP2-positive, tdTomato-negative cells were
identified as D2R-MSNs. Two-way ANOVA revealed significant
differences between genotype (F(1,8) 1128.7, p 0.0001), treat-
ment (F(1,8) 1334.9, p 0.0001), and a genotype treatment
interaction (F(1,8)  5220.2, p  0.0001). In control animals,
haloperidol treatment increased the percentage of D2R-MSNs
expressing c-FOS significantly compared with vehicle treatment
(Tukey’s post hoc adjusted: p  0.0001; Fig. 5C,E). Figure 5C
shows numerous c-FOS-expressing cells in a haloperidol-treated
control animal (top inset showshighmagnificationof all three labels
withyellowarrows indicatingD2R-MSNsexpressingc-FOS;bottom
inset shows c-FOS only). Strikingly, haloperidol administration
failed to induce c-FOS expression inD2R-MSNs fromERK:D2mu-
tants because we found virtually no c-FOS labeling in these mice
(Tukey’s post hoc adjusted: p 0.0001; Fig. 5D,E). We did not ob-
serve any changes in c-FOS expression inD1R-MSNs in any sample
group (Fig. 5F). These findings demonstrate that activity-induced
expressionof c-FOS is almost completely abolished inERK-deficient
D2R-MSNs.
Our observation that activity-induced c-FOS expression is de-
creased in ERK:D2 mice led us to investigate whether activity-
regulated synaptic plasticity geneswere similarly affected.Therefore,
we analyzed expression of the activity-induced synaptic cytoskel-
etal protein ARC in response to haloperidol or vehicle admi-
nistration in ERK:D2 mice and littermate controls. Two-way
ANOVA revealed significant differences between genotype (F(1,8) 
129.8, p  0.0001), treatment (F(1,8)  84.05, p  0.0001), and a
genotype treatment interaction (F(1,8) 80.89, p 0.0001). In
control animals, haloperidol treatment greatly increased the per-
centage of D2R-MSNs expressing ARC compared with vehicle
treatment (Tukey’s post hoc adjusted: p  0.0001; Fig. 5G,I).
Figure 5G shows numerous ARC-expressing cells in a halo-
peridol-treated control animal (top inset shows high magnification
of all three labels with yellow arrows indicatingD2R-MSNs express-
ing ARC; bottom inset shows the ARC label only). In contrast, we
observed minimal ARC expression in haloperidol-treated ERK:D2
mice (Tukey’s post hoc adjusted: haloperidol-treated ERK:D2 vs
control, p 0.0001; Fig. 5H,I, arrows in the top and bottom insets
showARC-deficient D2R-MSNs; green cells in the bottom inset are
D1R-MSNs expressing ARC).
Interestingly, we found that there is significantly increased
expression of ARC in D1R-MSNs of ERK:D2 mice in both
haloperidol- and vehicle-treated mutants compared with litter-
mate controls receiving the same treatment (Fig. 5J). Two-way
ANOVA revealed significant differences between genotype (F(1,8)
129.8, p 0.0001), treatment (F(1,8) 84.05, p 0.0001), and a
genotype  treatment interaction (F(1,8)  80.89, p  0.0001).
Although D1R-MSNs did not show hyperexcitability in acute slices
from ERK:D2 mice, it remains plausible that the network-level ho-
meostatic changes in D1R-MSN activity might account for this
result.
Discordant effects of ERK deletion between the D2-Cre and
Adora2-Cre line
In the D2-Cre line, Cre is expressed in a population of striatal
cholinergic interneurons in addition to D2R-MSNs (Kravitz et al.,
2010; Durieux et al., 2011). Therefore, we performed similar ex-
periments in the Adora2a-Cre line (A2a-Cre), which targets
D2R-MSNs but not cholinergic interneurons (Durieux et al.,
2009). Surprisingly, we found that ERK:A2amutantmice did not
recapitulate the open-field hyperlocomotor phenotype observed
in ERK:D2 mice. Total basal locomotor activity was unchanged
Table 1. Membrane and action potential properties of ERK:D2MSNs
Group IR (M
) RMP (mV) Rheo (pA) Thresh (mV) Amp (mV) H.W. (ms) MaxAPs
D2R Control 126 19 79.6 2.7 161 20 38.8 1.3 72.0 3.2 0.87 0.07 45.1 3.3
D2R Erk:D2 115 15 76.2 4.7 315 68* 29.4 4.5 52.8 7.7* 0.87 0.10 25.6 7.8*
D1R Control 87 12 85.6 2.0 204 16 38.5 2.2 73.1 4.6 0.87 0.06 37.7 2.9
D1R Erk:D2 73 6 76.9 4.6 252 18 33.9 2.1 68.3 4.4 0.87 0.05 36.7 2.4
Basic membrane properties and action potential properties in D2R-MSNs and D1R-MSNs recorded during intrinsic excitability experiments.
IR, Input resistance; RMP, resting membrane potential; Rheo, rheobase; Thresh, action potential threshold; Amp, action potential amplitude; H.W., half-width; MaxAPs, maximum number of action potentials for any current step.
*p 0.05 versus control neurons.
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between ERK:A2a and littermate control mice (Welch-corrected
t(10.24) 0.717, p 0.489; Fig. 6A). Likewise, the total locomotor
activity profile over the entire 1 h test session did not differ sig-
nificantly between ERK:A2a and control animals (repeated-
measures ANOVA; no main genotype effect, F(1,6)  1.137, p 
0.327; no time genotype interaction: F(5,30)  0.127, p  0.985;
Fig. 6B).
We next investigated whether ERK:A2a mutant mice also dif-
fered in their response to haloperidol. We first tested these ani-
mals for haloperidol-induced catalepsy. Interestingly, ERK:A2a
mutants responded similarly to ERK:D2mutant mice, showing a
significantly decreased cataleptic response to haloperidol admin-
istration compared with haloperidol-treated controls (Welch-
corrected t(6.86) 5.73, p 0.0008; Fig. 6C). Next, we sought to
determine whether haloperidol-induced changes in the expres-
sion of activity induced genes c-FOS and ARC in ERK:A2a mu-
tants. Consistent with our findings in ERK:D2mutants, there is a
significant reduction in c-FOS-expressing D2R-MSNs in ERK:
A2a mutant mice in response to haloperidol (Welch-corrected
t(3.61) 12.65, p 0.0004; Fig. 6D–F). Similarly, ARC expression
in D2R-MSNs is almost abolished in ERK:A2a mutant mice after
haloperidol administration (Welch-corrected t(3.24)  4.21, p 
0.021; Fig. 6G–I). Therefore, evidence from two independent
lines demonstrates that ERK is essential to the regulation of activity-
induced gene expression in D2R-MSNs.
Temporal delay in A2a-Cre mediated ERK deletion
To determinewhy ERK:D2 and ERK:A2amay differ in their basal
locomotor activities, we first verified that ERK2 expression was
ablated inD2R-MSNs of ERK:A2amice. Unexpectedly, we found
that a large proportion of D2R-MSNs expressed ERK2 protein at
P21 (Fig. 7A). At this stage, 40% of D2R-MSNs (45.16 
3.34%) maintained ERK2 expression (Fig. 7B). We repeated the
analysis at P28 and observed a decrease in ERK2-positive D2R-
MSNs; however,20% (16.89 3.91%) of D2R-MSNs still ex-
pressed ERK2 protein at this age (Fig. 7B). In contrast, ERK2
expression was effectively lost at P21 in ERK:D2D2R-MSNs (Fig.
1D). These findings suggest that the A2a-Cre mouse line shows
temporally delayed elimination of ERK activity in D2R-MSNs
compared with the D2-Cre mouse line.
The discrepancy between our ERK:D2 and ERK:A2a findings
suggests a potential spatiotemporal incongruity inCre expression
between the A2a-BAC and Drd2-BAC lines. To determine whether
theCre transgene is expressedeffectively inallD2R-MSNs in theA2a
line, we first backcrossed these mice with Ai9 Cre-dependent re-
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Figure 5. Activity-regulated gene expression is strongly suppressed in ERK-deleted D2R-
MSNs. A, Representative image of cataleptic response to haloperidol using horizontal bar test.
B, Quantification of cataleptic response (freezing) to haloperidol (1 mg/kg) or vehicle in litter-
mate control and ERK:D2 mutant mice. Control mice exhibit a robust cataleptic response to
haloperidol compared with vehicle-treated controls (*p 0.001, n 7 mice/genotype/con-
dition). The cataleptic response is effectively abolished in the mutant mice (*p  0.001,
haloperidol-treated ERK:D2 vs haloperidol treated control; n 7 mice/condition). Vehicle-
treated mice show no cataleptic response (n  7 mice per genotype per treatment).
4
C, D, c-FOS (green) expression in control and ERK:D2 mutant striatum 1 h after haloperidol
administration. CTIP2 (blue) identifies all MSNs; D1 tdTomato (red) identifies the D1R-MSN sub-
population. All D2R-MSNs are CTIP2();tdTomato(). Insets are magnified images showing
all three labels (top) and c-FOS only (bottom) demonstrating that c-FOS is strongly upregulated
in D2R-MSNs (yellow arrows) in control (C) but not ERK:D2 animals (D). E, Quantification of
MSN-specific c-FOS expression after haloperidol (1 mg/kg) or vehicle administration (*p
0.001; n 3 mice/genotype; 200–250 cells/mouse). F, No changes in c-FOS expression are
observed in D1R-MSNs in either control or ERK:D2 mutant animals. (n 3 animals/genotype,
200–250 cells/animal).G,H, ARC (green) expression in control and ERK:D2mutant striatum1h
after haloperidol administration. CTIP2 (blue) identifies allMSNs; D1 tdTomato (red) identifies the
D1R-MSN subpopulation. All D2R-MSNs are CTIP2();tdTomato(). Insets aremagnified im-
ages demonstrating that ARC is upregulated in D2R-MSNs (yellowarrows) in control (G) but not
ERK:D2 animals (H). I, Quantification of D2R-MSN-specific ARC expression after haloperidol
(1 mg/kg) or vehicle administration (*p  0.001; n  3 mice/genotype; 200–250 cells/
mouse). J, D1R-MSNs in ERK:D2 mutant mice express significantly more ARC compared with
controls regardless of treatment (#p 0.05, *p 0.001; n 3 mice/genotype; 200–250
cells/mouse). All data are presented as mean SEM. Scale bar, 50m; inset, 10m.
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porter mice, which label all Cre-expressing cells with tdTomato
fluorescent protein (Madisen et al., 2010). We then crossed these
A2a-Cre; Ai9 mice with D2-GFP BAC-transgenic mice, which
express GFP in all D2R-expressing cells (Gong et al., 2007) (Fig.
7C). The proportion of cells that expressed D2R-only (green),
A2a-only (red), or coexpressed both (A2a/D2; yellow) were then
quantified at multiple postnatal stages (Fig. 7D). At P14, approx-
imately one-third of labeled cells were D2 only (32.02 7.61%),
one-third were A2a only (34.51  3.55%), and the remaining
one-third coexpressed A2a and D2 (33.47 6.52%; Fig. 7D). At
P21, we observed an increase in A2a/D2 coexpression, however
nearly 25% of cells still did not show A2a recombination (D2
only: 26.33  4.88%; A2a only: 12.62  1.21%; A2a  D2:
61.05 3.74%; Fig. 7D). By P28, 15% of D2R-expressing cells still
had not undergone A2a-Cre-mediated recombination (D2 only:
14.45 5.06%;A2a only: 7.58 1.08%;A2aD2: 77.97 6.13%;
Fig. 7D). This result demonstrates that the A2a-Cre mouse line is
delayed in inducing genetic recombination in D2R-MSNs during
striatal development.
Discussion
ERK signaling is essential for MSN-pathway-specific
motor functions
The functions of ERK signaling in the striatum have been the
focus of numerous investigations due to the hypothesized impor-
tance of the pathway in normal striatal functions and in disease
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Figure 6. Basal and haloperidol-induced behavioral and gene expression changes in ERK:A2a mice. A, B, Open-field locomotor testing of ERK:A2a and control mice (n 7 animals/genotype).
A, There is no significant difference in cumulative distance traveled (1 h test) between ERK:A2a mutant and control littermates. B, Total distance traveled as a function of time. No differences are
observed between mutant and control animals. C, Cataleptic response 1 h after haloperidol administration (1 mg/kg). ERK:A2a mutant mice have a significantly reduced cataleptic response
comparedwith littermate controls (*p 0.001; n 6mice/genotype).D, E, Immunohistochemical labeling of activity-induced gene expression 1 h after haloperidol administration. All MSNs are
labeled with Ctip2 (blue). D1R-MSNs are distinguished from D2R-MSNs by their expression of D1 tdTomato(red). c-FOS (green) is upregulated in D2R-MSNs of control (D) but not ERK:A2amutant (E)
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percentage of D2R-MSNs expressing c-FOS in ERK:A2amutant animals comparedwith control animals (*p 0.001; n 3mice/genotype; 200–250 cells/mouse).G,H, ARC (green) is upregulated
in D2R-MSNs (yellow arrows) in control (G) but not ERK:A2a mutant (H) animals. I, Quantitative analysis demonstrating a significant decrease in the percentage of D2R-MSNs that upregulate ARC
in ERK:A2a mutant mice (*p 0.05; n 3 mice/genotype; 200–250 cells/mouse). All data are presented as mean SEM. Scale bars, 50m; inset, 20m.
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states (Fasano andBrambilla, 2011; Cerovic et al., 2013).Here, we
present the first genetic evidence that cell-type-specific elimina-
tion of ERK activity markedly impairs striatal pathway specific
motor functions. The severity of these phenotypes presumably
reflects the fact that multiple external stimuli (including neu-
rotransmitters and growth factors) and intrinsic neural activity
act via ERK to regulate MSN functions.
Deletion of both ERK1 and ERK2 in D2R-MSNs results in a
pronounced and long-lasting hyperlocomotor phenotype. The
intensity of this phenotype was unexpected given that germline
ERK1-KO mice show molecular and behavioral phenotypes in-
dicative of increased neuronal activity and ERK2-hypomorphic
mice fail to show locomotor defects (Selcher et al., 2001;Mazzuc-
chelli et al., 2002; Ferguson et al., 2006; Satoh et al., 2007; Engel et
al., 2009). However, our results are entirely consistent with stud-
ies showing that specific ablation of D2R-MSNs leads to marked
hyperlocomotor activity (Saito et al., 2001; Sano et al., 2003; Du-
rieux et al., 2009). ERK:D2 mice are also insensitive to the cata-
leptic effects of haloperidol, a response mediated by D2R-MSNs
(Sanberg, 1980; Farde et al., 1992). This insensitivity to haloper-
idol is also consistent with results obtained using genetic ablation
of D2R-MSNs (Durieux et al., 2012).
Given that ERK:D2mice show no evidence of cell death in the
striatum and that D2R-MSN axonal projections are appropri-
ately targeted and maintained, our data suggest that the behav-
ioral phenotypes observed are a result of dramatically reduced
functionality of D2R-MSNs. The hypolocomotive phenotype in
ERK:D1 mice also recapitulates D1R-MSN ablation, suggesting
that ERK activity is necessary for the proper function of both
MSNpopulations (Drago et al., 1998;Durieux et al., 2012; Re´vy et
al., 2014).
The dramatic decline in health and early lethality of ERK:D1
mice precluded a full analysis of this line. The changes in body-
weight andmovement after the first postnatal week are consistent
with previous findings in both dopamine-deficient mice and
knock-out models using D1-Cre (Zhou and Palmiter, 1995; Ko-
zorovitskiy et al., 2012). Presumably, ERK:D1 pups cannot ac-
quire nourishment during and after weaning.
ERK activity is required for D2R-MSN excitability
ERK:D2 mice exhibit a significantly reduced density of dendritic
spines on D2R-MSNs. Previous studies using genetic ERK mod-
els did not observe spine alterations (Satoh et al., 2007). Further,
D2R-specific knock-outs of BDNF-TrkB, an upstream activator
of ERK, failed to induce spine changes (Lobo et al., 2010; Besusso
et al., 2013). Coincidently, these BDNF-TrkB models also fail to
show locomotor changes until at least 1 year of age (Besusso et al.,
2013). Therefore, loss of ERK in D2R-MSNs leads to more strik-
ing defects in spinogenesis, as well as more dramatic changes in
locomotion, than does loss of BDNF/TrkB.
Changes in dendritic spine density are known to be associated
with changes in mEPSCs (Segal, 2005). Consistent with this idea,
D2R-MSNs from ERK:D2 mice exhibited a marked reduction in
the frequency of mEPSCs. These data suggest reduced excitatory
synaptic connectivity in D2R-MSNs. However, we cannot ex-
clude that changes in presynaptic release are also involved. This
striking change in synaptic efficacy has the potential to disrupt
patterned activity derived from cortical and thalamic excitatory
input onto D2R striatal neurons. The observed reduction in fre-
quency and amplitude of mIPSCs would have the potential to
further disrupt D2R-MSN circuit functions.
In addition to reduced synaptic strength, we observed a dra-
matic reduction in the intrinsic excitability of ERK-deficient
D2R-MSNs. Mechanisms that might explain this phenotype in-
clude loss of ERK-mediated phosphorylation of metabotropic or
ionotropic receptors or voltage gated ion channels (Sweatt, 2004).
For example, ERK phosphorylation regulates dendritic localiza-
tion of the voltage-gated potassium channel Kv4.2, which is
expressed abundantly in D2R-MSNs and serves to dampen neu-
ronal excitability (Adams et al., 2000; Yuan et al., 2002; Day et al.,
2008). Loss of ERK might lead to increased surface expression of
Kv4.2 and decreased neuronal excitability. Interestingly, in a re-
cent study of P14 excitatory cortical pyramidal neurons, condi-
tional ERK deletion resulted in hyperexcitability (Xing et al.,
2016).Whether these distinct effects on excitability represent dif-
ferences in ERK regulation in excitatory versus inhibitory neu-
rons or differences in the developmental stages studied is unclear
at present.
Regardless of mechanisms, the reductions of synaptic efficacy
and neuronal excitability observed in D2R-MSNs would likely
impair the functioning of D2R-MSNs in governingmotor behav-
ior. These effects on excitability may well explain the marked
hyperlocomotor activity thatweobserved inERK:D2mice. Further-
more these changes are potentially relevant to a number of patho-
logical states. For example, if similar ERK regulation of excitability
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occurs in D1R-MSNs, it would be relevant to L-Dopa-induced dys-
kinesia, which is known to be associated with striking increases in
ERK activity (Gerfen et al., 2002; Feyder et al., 2011). We note that
that theremay be differences in ERK regulation betweenD1R-MSN
andD2R-MSNs. Indeed, it has been shown that thePKA-dependent
phosphorylationofhistoneH3 in response to cell stimulation isERK
dependent in D1R-MSNs but ERK independent in D2R-MSNs
(Bertran-Gonzalez et al., 2009).
Expression of activity-regulated genes
Previous pharmacological and genetic studies investigating ERK
involvement in striatal activity-induced gene expression pro-
duced conflicting results. For instance, pan-striatal pharmaco-
logical blockade of ERK activity reduced activity-induced gene
expression in the striatum (Sgambato et al., 1998; Vanhoutte et
al., 1999; Zanassi et al., 2001), whereas germline ERK1 knock-out
mice showed increased IEG expression in the striatum (Mazzuc-
chelli et al., 2002; Ferguson et al., 2006). Our cell-type-specific
ablation of ERK activity in D2R-MSNs clearly demonstrate a
strong reduction of activity-regulated gene expression in D2R-
MSNs. Gene expression profiling at P17 showed markedly re-
duced expression of IEGs and synaptic plasticity genes in ERK:D2
mutant mice. We extended these observations using haloperidol
administration, which normally elicits strong activity-induced
expression of these genes (Bertran-Gonzalez et al., 2008). Even
upon stimulation with haloperidol, IEG gene expression was
largely abrogated in D2R-MSNs. Therefore, our data demon-
strate that ERK is critical for activity-induced gene expression in
MSNs in vivo, a process that is essential for driving neuronal
synaptic plasticity and adaptations in basal ganglia circuits (Fla-
vell and Greenberg, 2008; West and Greenberg, 2011).
ERK is thought to control activity-mediated gene expression
via activation of a number of critical transcription factors (Gi-
rault et al., 2007). However, in ERK-deficient D2R MSNs, it re-
mains unclear whether the reduction in activity-induced gene
expression is a direct effect of ERK pathway transcriptional reg-
ulation or if the reduced neuronal excitability in the ERK-deleted
MSNs also plays a role. ERK deficiency may also impair transla-
tion of local mRNA stores in response to stimuli (O’Donnell et
al., 2012). Finally, effects of ERK deficiency could be due to reg-
ulation of developmental events (see below). Future studies that
ablate ERK activity inducibly will be important in further defin-
ing ERK-dependent mechanisms in adult MSNs.
Differences in phenotypes between Adora2a- and D2-Cre
ERK-deficient mice
Our studies show a concordance of phenotypes between ERK:D2
mice and ERK:A2amice in regard to their resistance to haloperidol-
induced catalepsy and loss of activity-induced gene expression. A
surprising result is that ERK:A2a mice do not exhibit the hyper-
locomotor phenotype seen in the ERK:D2mouse line. A possible
explanation is related to different patterns of recombination
between the D2-Cre and A2a-Cre mouse lines. Although D2-Cre
mice target a small population of cholinergic interneurons in the
striatum, A2a-Cre-transgenic mice reportedly do not target the
cholinergic population (Durieux et al., 2009; Kozorovitskiy et al.,
2012; Kharkwal et al., 2016). However, preservation of ERK in
cholinergic neurons in the A2a line is unlikely to account for the
behavioral difference because cholinergic interneurons ulti-
mately act on the MSN population. For example, a recent study
showed that haloperidol-induced changes in cholinergic neuron
activity were relayed directly to D2R-MSNs to mediate cataleptic
effects (Kharkwal et al., 2016).
Amore likely explanation for the different observed behaviors
is the temporal delay in Cre-mediated ERK2 deletion in the ERK:
A2a mice. At P21, nearly 45% of D2R-MSNs continue to express
ERK2 in ERK:A2a mice compared with only 3% in ERK:D2 mu-
tants. Even at P28, almost 20% of D2R-MSNs still express ERK in
A2a-Cre mice. These findings argue that the loss of ERK activity
specifically in D2R-MSNs before or during the “critical period”
of network formation (Tepper et al., 1998; Kozorovitskiy et al.,
2012) results in hyperlocomotor behavior, whereas loss after the
critical period results in a milder phenotype. Therefore, reduc-
tions in ERK/MAP activity before or during the critical period
may lead to long-lasting modifications of circuit function and
behavioral abnormalities. This concept may be pertinent to the
etiology of developmental hyperkinetic disorders such as attention
deficit hyperactivity disorder (Faraone et al., 2015; Rosenberg et al.,
2016). The observation that ERK:A2a mice, which exhibit delayed
recombination, show impaired expression of activity-regulated
genes in response to haloperidol in adulthood underscores the im-
portance of ERK functions in neural plasticity even beyond the crit-
ical period.
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